8-23224952-A-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_003844.4(TNFRSF10A):ā€‹c.110T>Gā€‹(p.Val37Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000302 in 1,600,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00024 ( 0 hom., cov: 30)
Exomes š‘“: 0.00031 ( 0 hom. )

Consequence

TNFRSF10A
NM_003844.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.574
Variant links:
Genes affected
TNFRSF10A (HGNC:11904): (TNF receptor superfamily member 10a) The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL), and thus transduces cell death signal and induces cell apoptosis. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. [provided by RefSeq, Jul 2008]
TNFRSF10A-DT (HGNC:52647): (TNFRSF10A divergent transcript)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062499344).
BS2
High AC in GnomAd4 at 37 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TNFRSF10ANM_003844.4 linkuse as main transcriptc.110T>G p.Val37Gly missense_variant 1/10 ENST00000221132.8 NP_003835.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TNFRSF10AENST00000221132.8 linkuse as main transcriptc.110T>G p.Val37Gly missense_variant 1/101 NM_003844.4 ENSP00000221132 P1
TNFRSF10AENST00000613472.1 linkuse as main transcriptc.31+79T>G intron_variant 1 ENSP00000480778
TNFRSF10A-DTENST00000517774.1 linkuse as main transcriptn.421+61A>C intron_variant, non_coding_transcript_variant 4

Frequencies

GnomAD3 genomes
AF:
0.000244
AC:
37
AN:
151850
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000332
AC:
74
AN:
222940
Hom.:
0
AF XY:
0.000304
AC XY:
37
AN XY:
121600
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000678
Gnomad ASJ exome
AF:
0.00254
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000264
Gnomad OTH exome
AF:
0.000359
GnomAD4 exome
AF:
0.000309
AC:
447
AN:
1448248
Hom.:
0
Cov.:
31
AF XY:
0.000284
AC XY:
204
AN XY:
719320
show subpopulations
Gnomad4 AFR exome
AF:
0.0000603
Gnomad4 AMR exome
AF:
0.000555
Gnomad4 ASJ exome
AF:
0.00279
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000303
Gnomad4 OTH exome
AF:
0.000234
GnomAD4 genome
AF:
0.000243
AC:
37
AN:
151968
Hom.:
0
Cov.:
30
AF XY:
0.000269
AC XY:
20
AN XY:
74276
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000523
Gnomad4 ASJ
AF:
0.00346
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000250
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000459
Hom.:
0
Bravo
AF:
0.000336
ExAC
AF:
0.000215
AC:
26

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 27, 2021The c.110T>G (p.V37G) alteration is located in exon 1 (coding exon 1) of the TNFRSF10A gene. This alteration results from a T to G substitution at nucleotide position 110, causing the valine (V) at amino acid position 37 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
8.9
DANN
Benign
0.43
DEOGEN2
Benign
0.0018
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0078
N
LIST_S2
Benign
0.21
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.0062
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.0
N
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.37
T
PROVEAN
Benign
0.20
N
REVEL
Benign
0.20
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.065
T
Polyphen
0.13
B
Vest4
0.13
MVP
0.17
MPC
0.084
ClinPred
0.022
T
GERP RS
-1.4
Varity_R
0.11
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs549217117; hg19: chr8-23082465; API